Alan Au
Director
pharmaceutical
Celluar Biomedicine
China
Biography
Mr. Au is a seasoned banker for healthcare companies. He has over 15 years of experience in cross boarder merger and acquisition and financing transactions for pharmaceutical and healthcare companies. Mr. Au is a currently senior adviser to the Board of Directors of Simcere Pharmaceutical Group (NYSE:SCR), a China-based pharmaceutical company that used to be listed on the New York Stock Exchange, and a venture partner of Ally Bridge Group, a biotech-focused investment fund headquartered in Hong Kong. He also serves on the assessment panel of the Small Entrepreneur Research Assistance Program (SERAP) for the Innovation and Technology Commission of the Hong Kong SAR Government.
Research Interest
pharmaceutical
